A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer.
Journal
NAR cancer
ISSN: 2632-8674
Titre abrégé: NAR Cancer
Pays: England
ID NLM: 101769553
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
18
06
2021
revised:
24
11
2021
accepted:
15
12
2021
entrez:
20
1
2022
pubmed:
21
1
2022
medline:
21
1
2022
Statut:
epublish
Résumé
Although microRNAs (miRNAs) contribute to all hallmarks of cancer, miRNA dysregulation in metastasis remains poorly understood. The aim of this work was to reliably identify miRNAs associated with metastatic progression of colorectal cancer (CRC) using novel and previously published next-generation sequencing (NGS) datasets generated from 268 samples of primary (pCRC) and metastatic CRC (mCRC; liver, lung and peritoneal metastases) and tumor adjacent tissues. Differential expression analysis was performed using a meticulous bioinformatics pipeline, including only bona fide miRNAs, and utilizing miRNA-tailored quality control and processing. Five miRNAs were identified as up-regulated at multiple metastatic sites Mir-210_3p, Mir-191_5p, Mir-8-P1b_3p [mir-141-3p], Mir-1307_5p and Mir-155_5p. Several have previously been implicated in metastasis through involvement in epithelial-to-mesenchymal transition and hypoxia, while other identified miRNAs represent novel findings. The use of a publicly available pipeline facilitates reproducibility and allows new datasets to be added as they become available. The set of miRNAs identified here provides a reliable starting-point for further research into the role of miRNAs in metastatic progression.
Identifiants
pubmed: 35047825
doi: 10.1093/narcan/zcab051
pii: zcab051
pmc: PMC8759566
doi:
Types de publication
Journal Article
Langues
eng
Pagination
zcab051Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.
Références
Nature. 2007 Oct 11;449(7163):682-8
pubmed: 17898713
J Pathol. 2009 Oct;219(2):214-21
pubmed: 19593777
Oncotarget. 2016 Feb 9;7(6):6476-505
pubmed: 26623728
Int J Oncol. 2014 Aug;45(2):603-10
pubmed: 24889194
Oncotarget. 2016 Jan 26;7(4):3857-72
pubmed: 26646696
Nucleic Acids Res. 2020 Jan 8;48(D1):D132-D141
pubmed: 31598695
Nat Rev Cancer. 2009 Apr;9(4):274-84
pubmed: 19308067
Cancer Res. 2015 Aug 1;75(15):3010-9
pubmed: 26069251
Oncol Lett. 2016 Jul;12(1):488-494
pubmed: 27347170
Cancer Cell Int. 2020 Oct 12;20:502
pubmed: 33061854
Biochem Biophys Res Commun. 2013 Jun 14;435(4):745-50
pubmed: 23707940
Oncogenesis. 2015 Oct 05;4:e170
pubmed: 26436952
Clin Chem. 2010 Jun;56(6):998-1006
pubmed: 20378769
Nucleic Acids Res. 2017 Sep 19;45(16):9290-9301
pubmed: 28934507
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):187-97
pubmed: 25315964
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Nat Biotechnol. 2017 Sep;35(9):872-878
pubmed: 28829439
PLoS One. 2012;7(4):e34150
pubmed: 22529906
Science. 2016 Apr 8;352(6282):175-80
pubmed: 27124451
PLoS One. 2013 Jul 02;8(7):e67461
pubmed: 23874421
Nat Methods. 2012 Jul 01;9(8):840-6
pubmed: 22751203
Sci Rep. 2016 Jul 15;6:29765
pubmed: 27416752
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
Nat Biotechnol. 2010 Apr;28(4):341-7
pubmed: 20351690
Cancer Med. 2020 Oct;9(20):7558-7571
pubmed: 32864858
Mol Cancer Res. 2003 Oct;1(12):882-91
pubmed: 14573789
Nat Cell Biol. 2013 Jun;15(6):546-54
pubmed: 23728460
Oncotarget. 2017 Jul 18;8(44):76290-76304
pubmed: 29100312
Cell. 2014 May 22;157(5):1104-16
pubmed: 24855947
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
Annu Rev Genet. 2015;49:213-42
pubmed: 26473382
PeerJ. 2018 Jan 12;6:e4262
pubmed: 29340253
Biomark Res. 2021 Mar 12;9(1):18
pubmed: 33712063
BMC Cancer. 2012 Nov 02;12:505
pubmed: 23121918
Cancers (Basel). 2020 Dec 18;12(12):
pubmed: 33352935
Cell Death Dis. 2017 Jul 27;8(7):e2958
pubmed: 28749470
Cell Discov. 2015 May 19;1:15005
pubmed: 27462406
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
Scand J Clin Lab Invest Suppl. 2016;245:S80-3
pubmed: 27542003
PLoS One. 2013 Jun 18;8(6):e66165
pubmed: 23824282
Oncol Lett. 2014 Aug;8(2):711-713
pubmed: 25013489
NAR Genom Bioinform. 2021 Jul 21;3(3):lqab068
pubmed: 34308351
Microcirculation. 2012 Apr;19(3):215-23
pubmed: 22171547
Genome Biol. 2018 Dec 4;19(1):213
pubmed: 30514392
RNA Biol. 2016 Nov;13(11):1103-1116
pubmed: 27645402
Dis Model Mech. 2017 Mar 1;10(3):197-214
pubmed: 28250048
Nat Cell Biol. 2008 May;10(5):593-601
pubmed: 18376396
J Exp Clin Cancer Res. 2014 Dec 31;33:113
pubmed: 25551793
PLoS One. 2018 Aug 3;13(8):e0201809
pubmed: 30075027
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832
Nucleic Acids Res. 2014 Jul;42(12):7528-38
pubmed: 24875473
Genome Res. 2017 Oct;27(10):1769-1781
pubmed: 28877962
Oncogene. 2006 Oct 9;25(46):6170-5
pubmed: 17028596
mBio. 2015 Dec 08;6(6):e01500-15
pubmed: 26646011